Avaleht › Müeloom › Washington › Tacoma
Müeloom kliinilised uuringud linnas Tacoma, WA
13 uuringut haiguse Müeloom jaoks otsivad osalejaid linnas Tacoma ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
VärbamineFaas 3
- Study Site 103, Tacoma
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
VärbamineFaas 3
- Research Site, Puyallup · 8 mi kaugusel
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
VärbamineFaas 3
- NorthWest Medical Specialties, PLLC, Tacoma
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
VärbamineFaas 4
- Northwest Medical Specialties, PLLC, Tacoma
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
VärbamineFaas 3
- NorthWest Medical Specialties, PLLC, Tacoma
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
VärbamineFaas 1
- American Oncology Network Vista Oncology Division / Physician partner associate, Olympia · 26 mi kaugusel
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
VärbamineFaas 2
- Northwest Medical Specialties, Tacoma
- Northwest Medical Specialties, Gig Harbor · 8 mi kaugusel
- Northwest Medical Specialties, Puyallup · 8 mi kaugusel
- ja veel 1
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
VärbamineFaas 1/2
- Northwest Medical Specialties Tacoma /ID# 272506, Tacoma
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
VärbamineFaas 1
- Northwest Medical Specialties, Tacoma
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
VärbamineFaas 3
- Research Site, Puyallup · 8 mi kaugusel
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
VärbamineFaas 1
- Northwest Medical Specialties Tacoma /ID# 267117, Tacoma
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
VärbamineFaas 3
- Providence Regional Cancer System-Yelm, Yelm · 23 mi kaugusel
- Providence Regional Cancer System-Lacey, Lacey · 23 mi kaugusel
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
VärbamineFaas 3
- GSK Investigational Site, Puyallup · 8 mi kaugusel
Müeloom uuringud teistes linnades
- New York City, NY60 uuringut
- Boston, MA42 uuringut
- Atlanta, GA41 uuringut
- Houston, TX38 uuringut
- Durham, NC37 uuringut
- Nashville, TN32 uuringut
- Denver, CO27 uuringut
- Rochester, MN24 uuringut
- St. Louis, MO24 uuringut
- Columbus, OH24 uuringut
- Baldwin Park, CA23 uuringut
- Chicago, IL22 uuringut
Muud uuringud linnas Tacoma
- Mitteväikerakuline kopsuvähk20 uuringut
- Rinnavähk18 uuringut
- Haavandiline koliit15 uuringut
- Eesnäärmevähk11 uuringut
- Crohni tõbi11 uuringut
- Metastaatiline vähk9 uuringut
- Käär- ja pärasoolevähk9 uuringut
- Melanoom7 uuringut
- Munasarjavähk7 uuringut
- Vähk (kõik liigid)6 uuringut
- Pankreasevähk6 uuringut
- Rasvumine6 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.